DK0707567T3 - Fremgangsmåde til syntese af azetidinoner - Google Patents

Fremgangsmåde til syntese af azetidinoner

Info

Publication number: DK0707567T3
Authority: DK; Denmark
Prior art keywords: substituted; pct; beta; amino; azetidinones
Prior art date: 1993-07-09

Application number

DK94921407T

Other languages

Danish (da)

English (en)

Inventor

Chou-Hong Tann

Tiruvettipuram K Thiruvengadam

Timothy Mcallister

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-09

Filing date

1994-07-01

Publication date

2001-11-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22217215&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0707567(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-07-01 Application filed by Schering Corp filed Critical Schering Corp

2001-11-26 Application granted granted Critical

2001-11-26 Publication of DK0707567T3 publication Critical patent/DK0707567T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Steroid Compounds (AREA)

DK94921407T 1993-07-09 1994-07-01 Fremgangsmåde til syntese af azetidinoner DK0707567T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8935793A	1993-07-09	1993-07-09
PCT/US1994/007291 WO1995001961A1 (en)	1993-07-09	1994-07-01	Process for the synthesis of azetidinones

Publications (1)

Publication Number	Publication Date
DK0707567T3 true DK0707567T3 (da)	2001-11-26

Family

ID=22217215

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94921407T DK0707567T3 (da)	1993-07-09	1994-07-01	Fremgangsmåde til syntese af azetidinoner

Country Status (21)

Country	Link
US (1)	US5728827A (cs)
EP (1)	EP0707567B1 (cs)
JP (1)	JP2840452B2 (cs)
KR (1)	KR0176001B1 (cs)
CN (1)	CN1071745C (cs)
AT (1)	ATE205475T1 (cs)
AU (1)	AU681419B2 (cs)
CA (1)	CA2166784C (cs)
CZ (1)	CZ7696A3 (cs)
DE (1)	DE69428280T2 (cs)
DK (1)	DK0707567T3 (cs)
ES (1)	ES2160125T3 (cs)
FI (1)	FI960095A7 (cs)
HU (1)	HUT73237A (cs)
MX (1)	MX9405152A (cs)
NO (1)	NO306294B1 (cs)
NZ (1)	NZ268798A (cs)
PL (1)	PL312502A1 (cs)
PT (1)	PT707567E (cs)
SK (1)	SK3796A3 (cs)
WO (1)	WO1995001961A1 (cs)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5631365A (en)	1993-09-21	1997-05-20	Schering Corporation	Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
EP1137634B1 (en) *	1998-12-07	2005-06-15	Schering Corporation	Process for the synthesis of azetidinones
US6207822B1 (en)	1998-12-07	2001-03-27	Schering Corporation	Process for the synthesis of azetidinones
AR023463A1 (es)	1999-04-16	2002-09-04	Schering Corp	Uso de compuestos de azetidinona
US6982251B2 (en)	2000-12-20	2006-01-03	Schering Corporation	Substituted 2-azetidinones useful as hypocholesterolemic agents
HU230253B1 (hu) *	2001-01-26	2015-11-30	Merck Sharp & Dohme Corp	Peroxiszóma proliferátor-aktivált receptor (PPAR) aktivátor(ok) és szterin-abszorpció inhibitor(ok) kombinációi és alkalmazásuk vaszkuláris indikációk kezelésére
US7071181B2 (en)	2001-01-26	2006-07-04	Schering Corporation	Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
US20060287254A1 (en) *	2001-01-26	2006-12-21	Schering Corporation	Use of substituted azetidinone compounds for the treatment of sitosterolemia
DK1355644T3 (da)	2001-01-26	2006-10-23	Schering Corp	Anvendelse af substituerede azetidinonforbindelser til behandling af sitosterolæmi
DK1373230T3 (da) *	2001-03-28	2005-11-07	Schering Corp	Enantiselektiv syntese af azetidinon mellemprodukter
JP2005504091A (ja)	2001-09-21	2005-02-10	シェーリング　コーポレイション	ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
US7053080B2 (en)	2001-09-21	2006-05-30	Schering Corporation	Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US20030204096A1 (en) *	2002-03-25	2003-10-30	Schering Corporation	Enantioselective synthesis of azetidinone intermediate compounds
GB0215579D0 (en)	2002-07-05	2002-08-14	Astrazeneca Ab	Chemical compounds
US7135556B2 (en) *	2002-07-19	2006-11-14	Schering Corporation	NPC1L1 (NPC3) and methods of use thereof
WO2004043457A1 (en)	2002-11-06	2004-05-27	Schering Corporation	Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
JP4589919B2 (ja) *	2003-03-07	2010-12-01	シェーリングコーポレイション	高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
US7459442B2 (en) *	2003-03-07	2008-12-02	Schering Corporation	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
CA2517571C (en) *	2003-03-07	2011-07-05	Schering Corporation	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP2006519869A (ja)	2003-03-07	2006-08-31	シェーリング　コーポレイション	置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
AU2004308332B2 (en) *	2003-12-23	2008-04-10	Merck Sharp & Dohme Corp.	Anti-hypercholesterolemic compounds
ATE485267T1 (de)	2003-12-23	2010-11-15	Astrazeneca Ab	Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung
JP4590417B2 (ja) *	2004-01-16	2010-12-01	メルク・シャープ・エンド・ドーム・コーポレイション	Ｎｐｃ１ｌ１（ｎｐｃ３）およびこのリガンドの同定方法
DE102004025071B4 (de) *	2004-05-21	2006-12-21	Sanofi-Aventis Deutschland Gmbh	Verfahren zur Herstellung von Diphenylazetidinon-Derivaten
ATE376997T1 (de)	2004-05-21	2007-11-15	Sanofi Aventis Deutschland	Verfahren zur herstellung von 1,4- diphenylazetidinon-derivaten
EP1831162B1 (en)	2004-12-20	2012-10-31	Merck Sharp & Dohme Corp.	Process for the synthesis of azetidinones
TW200738676A (en) *	2005-06-20	2007-10-16	Schering Corp	Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
SA06270191B1 (ar)	2005-06-22	2010-03-29	استرازينيكا ايه بي	مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
US7910698B2 (en) *	2006-02-24	2011-03-22	Schering Corporation	NPC1L1 orthologues
TW200811098A (en)	2006-04-27	2008-03-01	Astrazeneca Ab	Chemical compounds
US20080103122A1 (en) *	2006-09-05	2008-05-01	Schering Corporation	Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis
WO2008032338A2 (en) *	2006-09-11	2008-03-20	Manne Satyanarayana Reddy	Improved process for the preparation of ezetimibe and its intermediates
EA017349B1 (ru)	2007-01-24	2012-11-30	Крка	Способ получения эзетимиба и его производных
WO2010113175A2 (en)	2009-04-01	2010-10-07	Matrix Laboratories Ltd	Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
CN104803858B (zh) *	2014-01-23	2019-03-01	东莞东阳光科研发有限公司	一种制备四丁基氟化铵三水合物的方法
HRP20241159T1 (hr)	2020-02-07	2024-12-06	Gasherbrum Bio, Inc.	Heterociklički agonisti za glp-1
CN116368140A (zh)	2020-09-10	2023-06-30	加舒布鲁姆生物公司	杂环glp-1激动剂
CN120957993A (zh)	2023-02-16	2025-11-14	加舒布鲁姆生物公司	杂环glp-1激动剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0333268A1 (en) *	1988-03-18	1989-09-20	Merck & Co. Inc.	Process for synthesis of a chiral 3-beta hydrogen (3R) 4-aroyloxy azetidinone
US4876365A (en) *	1988-12-05	1989-10-24	Schering Corporation	Intermediate compounds for preparing penems and carbapenems
US4983597A (en) *	1989-08-31	1991-01-08	Merck & Co., Inc.	Beta-lactams as anticholesterolemic agents
US5085473A (en) *	1990-10-09	1992-02-04	Yuhe Yang	Air actuated car curtain device
JP2525125B2 (ja) *	1991-07-23	1996-08-14	シェリング・コーポレーション	血清コレステロ―ル低下薬として有用な置換β−ラクタム化合物およびそれらの製法

1994
- 1994-07-01 WO PCT/US1994/007291 patent/WO1995001961A1/en not_active Ceased
- 1994-07-01 ES ES94921407T patent/ES2160125T3/es not_active Expired - Lifetime
- 1994-07-01 CZ CZ9676A patent/CZ7696A3/cs unknown
- 1994-07-01 AT AT94921407T patent/ATE205475T1/de active
- 1994-07-01 CN CN94192732A patent/CN1071745C/zh not_active Expired - Fee Related
- 1994-07-01 KR KR1019960700068A patent/KR0176001B1/ko not_active Expired - Fee Related
- 1994-07-01 EP EP94921407A patent/EP0707567B1/en not_active Expired - Lifetime
- 1994-07-01 CA CA002166784A patent/CA2166784C/en not_active Expired - Fee Related
- 1994-07-01 SK SK37-96A patent/SK3796A3/sk unknown
- 1994-07-01 US US08/578,594 patent/US5728827A/en not_active Expired - Lifetime
- 1994-07-01 DK DK94921407T patent/DK0707567T3/da active
- 1994-07-01 AU AU72146/94A patent/AU681419B2/en not_active Ceased
- 1994-07-01 FI FI960095A patent/FI960095A7/fi unknown
- 1994-07-01 PL PL94312502A patent/PL312502A1/xx unknown
- 1994-07-01 HU HU9503748A patent/HUT73237A/hu unknown
- 1994-07-01 PT PT94921407T patent/PT707567E/pt unknown
- 1994-07-01 DE DE69428280T patent/DE69428280T2/de not_active Expired - Lifetime
- 1994-07-01 NZ NZ268798A patent/NZ268798A/en unknown
- 1994-07-01 JP JP7504054A patent/JP2840452B2/ja not_active Expired - Fee Related
- 1994-07-06 MX MX9405152A patent/MX9405152A/es not_active IP Right Cessation
1996
- 1996-01-08 NO NO960083A patent/NO306294B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL312502A1 (en)	1996-04-29
MX9405152A (es)	1995-01-31
FI960095L (fi)	1996-01-09
JPH08507085A (ja)	1996-07-30
CA2166784C (en)	2001-12-11
NO306294B1 (no)	1999-10-18
ATE205475T1 (de)	2001-09-15
DE69428280D1 (de)	2001-10-18
EP0707567B1 (en)	2001-09-12
EP0707567A1 (en)	1996-04-24
DE69428280T2 (de)	2002-06-13
NO960083D0 (no)	1996-01-08
JP2840452B2 (ja)	1998-12-24
NZ268798A (en)	1997-01-29
FI960095A0 (fi)	1996-01-09
NO960083L (no)	1996-03-04
US5728827A (en)	1998-03-17
SK3796A3 (en)	1997-02-05
CN1071745C (zh)	2001-09-26
HUT73237A (en)	1996-07-29
HU9503748D0 (en)	1996-02-28
KR0176001B1 (ko)	1999-03-20
CZ7696A3 (en)	1996-04-17
WO1995001961A1 (en)	1995-01-19
FI960095A7 (fi)	1996-01-09
CN1126989A (zh)	1996-07-17
PT707567E (pt)	2002-01-30
ES2160125T3 (es)	2001-11-01
KR960703853A (ko)	1996-08-31
AU7214694A (en)	1995-02-06
CA2166784A1 (en)	1995-01-19
AU681419B2 (en)	1997-08-28

Publication	Publication Date	Title
DK0707567T3 (da)	2001-11-26	Fremgangsmåde til syntese af azetidinoner
MY138525A (en)	2009-06-30	Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
PL318100A1 (en)	1997-05-12	2-[(dihydro) pyrazolyl-3'-oxymethylene]anilides, method of obtaining them and their application
PT934325E (pt)	2004-10-29	Trisanidridos biciclicos de tetrafosfonato
ZA9811576B (en)	2000-06-19	Anilide derivative, production and use thereof.
DK0703788T3 (da)	2002-05-21	Stabiliseret phenylalaninammoniaklyase
MX9703564A (es)	1997-08-30	Inhibidores de proteasa multicatalitica.
BG108168A (en)	2004-09-30	Enantioselective synthesis of azetidinone intermediate compounds
MXPA04005847A (es)	2004-09-13	Compuestos derivados de 4-sulfuro/sulfoxido/sulfonil-1h-pirazolilo, para uso en enfermedades asociadas con el receptor 5-ht2c.
MX9708621A (es)	1998-02-28	AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS.
ATE207929T1 (de)	2001-11-15	Diastereomerenreine 3-oxo und 3-thioxo-4-aza- androstanderivate und ihre verwendung als antiandrogene
DK0687260T3 (da)	2003-06-10	Fremgangsmåde til fremstillingen af 9-desoxotaxaner
YU78303A (sh)	2006-05-25	Postupak za dobijanje 1,3-supstituisanih indena i azapolicikličnih jedinjenja sa pripojenim arilom
ID23053A (id)	2000-01-20	Karboksamida yang digunakan sebagai agonis 5-ht <if>
NZ331875A (en)	2000-01-28	Asymmetric synthesis of R-alpha-propyl-piperonyl amine and its analogs
ZA961364B (en)	1996-08-22	1-Aryl-2-acylamino-ethane compounds
BG104243A (en)	2001-05-31	Method for the synthesis of quinoline derivatives
IL172973A (en)	2010-11-30	Process for the preparation of (4s, 5r) - n - boc - 2 - (2' 4 - dimethoxyphenyl) - 4 - isobutyl - 1 - oxazolidine - 5 - carboxylic acid
MY133666A (en)	2007-11-30	Enzymatic process for stereoselective preparation of therapeutic amides
MX9701569A (es)	1997-05-31	Pirimidin(tio)onas substituidas.
TR199701298T1 (xx)	1998-02-21	Tetralinler.
NO20030609L (no)	2003-02-07	Fremgangsmåte for fremstilling av baccatin III-derivater
MXPA04004980A (es)	2004-08-11	Antagonistas del receptor ccr-3.
PL324247A1 (en)	1998-05-11	Novel 1-amino-3-benzyluracils
TR200001122T2 (tr)	2000-08-21	Farmasötikler olarak bifenil türevleri.